Novo Nordisk A/S

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DK0062498333
DKK
309.60
5.8 (1.91%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
76,857.00
78,087.00
85,683.00
71,311.00
68,060.00
65,349.00
65,863.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
76,857.00
78,087.00
85,683.00
71,311.00
68,060.00
65,349.00
65,863.00
Raw Material Cost
12,846.00
12,890.00
13,024.00
11,308.00
10,274.00
9,916.00
10,014.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4,958.00
5,183.00
5,093.00
0.00
1,562.00
2,074.00
0.00
Selling and Distribution Expenses
18,849.00
16,112.00
20,281.00
16,592.00
16,091.00
14,413.00
18,626.00
Other Expenses
673.20
512.50
870.90
948.80
1,460.40
653.20
1,046.00
Total Expenditure (Excl Depreciation)
43,385.00
39,310.00
47,107.00
37,388.00
42,531.00
32,935.00
39,100.00
Operating Profit (PBDIT) excl Other Income
33472
38777
38576
33923
25529
32414
26763
Other Income
5,291.00
3,439.00
2,074.00
461.00
1,365.00
1,578.00
857.00
Operating Profit (PBDIT)
43,596.00
46,046.00
45,848.00
36,534.00
35,739.00
36,906.00
30,612.00
Interest
4,958.00
5,183.00
5,093.00
0.00
1,562.00
2,074.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
64,011.00
65,197.00
72,659.00
60,003.00
57,786.00
55,433.00
55,849.00
Depreciation
4,833.00
3,830.00
5,198.00
2,150.00
8,845.00
2,914.00
2,992.00
Profit Before Tax
33,805.00
37,033.00
35,557.00
34,384.00
25,332.00
31,918.00
27,620.00
Tax
7,302.00
7,999.00
7,327.00
7,083.00
5,282.00
6,511.00
5,657.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
26,503.00
29,034.00
28,230.00
27,301.00
20,050.00
25,407.00
21,963.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
26,503.00
29,034.00
28,230.00
27,301.00
20,050.00
25,407.00
21,963.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
26,503.00
29,034.00
28,230.00
27,301.00
20,050.00
25,407.00
21,963.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Reserves
1,68,066.00
1,38,540.00
1,43,486.00
1,20,522.00
1,12,522.00
98,911.00
1,06,561.00
Earnings per share (EPS)
5.96
6.49
6.34
6.12
4.49
5.68
4.91
Diluted Earnings per share
5.96
6.49
6.34
6.12
4.49
5.68
4.91
Operating Profit Margin (Excl OI)
43.55%
49.66%
45.02%
47.57%
37.51%
49.6%
40.63%
Gross Profit Margin
50.27%
52.33%
47.56%
51.23%
50.22%
53.3%
46.48%
PAT Margin
34.48%
37.18%
32.95%
38.28%
29.46%
38.88%
33.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 12.93% vs 25.34% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 32.18% vs 3.20% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 11.44% vs 31.80% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 217.41% vs 0.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Novo Nordisk A/S With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Net Sales
76,857.00
6,084.63
70,772.37
1,163.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
76,857.00
6,084.63
70,772.37
1,163.13%
Raw Material Cost
12,846.00
374.95
12,471.05
3,326.06%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4,958.00
59.20
4,898.80
8,275.00%
Selling and Distribution Expenses
18,849.00
947.23
17,901.77
1,889.91%
Other Expenses
673.20
233.52
439.68
188.28%
Total Expenditure (Excl Depreciation)
43,385.00
3,716.56
39,668.44
1,067.34%
Operating Profit (PBDIT) excl Other Income
33,472.00
2,368.07
31,103.93
1,313.47%
Other Income
5,291.00
473.61
4,817.39
1,017.16%
Operating Profit (PBDIT)
43,596.00
2,841.69
40,754.31
1,434.16%
Interest
4,958.00
59.20
4,898.80
8,275.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
64,011.00
5,709.69
58,301.31
1,021.09%
Depreciation
4,833.00
0.00
4,833.00
Profit Before Tax
33,805.00
2,782.49
31,022.51
1,114.92%
Tax
7,302.00
572.28
6,729.72
1,175.95%
Provisions and contingencies
0
0
0.00
Profit After Tax
26,503.00
2,210.20
24,292.80
1,099.12%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
26,503.00
2,210.20
24,292.80
1,099.12%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
26,503.00
2,210.20
24,292.80
1,099.12%
Equity Capital
0
0
0.00
Face Value
0.10
6.36
0.00
Reserves
1,68,066.00
33,698.45
1,34,367.55
398.74%
Earnings per share (EPS)
5.96
35.94
-29.98
-83.42%
Diluted Earnings per share
5.96
35.94
-29.98
-83.42%
Operating Profit Margin (Excl OI)
43.55%
38.92%
0.00
4.63%
Gross Profit Margin
50.27%
45.73%
0.00
4.54%
PAT Margin
34.48%
36.32%
0.00
-1.84%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7,685.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -1.58% vs -8.87% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.93% vs 25.34% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2,650.30 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -8.72% vs 2.85% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 32.18% vs 3.20% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,830.50 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -10.10% vs -2.67% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 11.44% vs 31.80% in Jun 2024

Quarterly - Interest
Interest 495.80 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -4.34% vs 1.77% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 217.41% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 43.55%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024